Concord Biotech IPO: What does GMP signal as focus shifts to allotment

Concord Biotech IPO: The initial public offering (IPO) of Rekha Jhunjhunwala-backed Concord Biotech garnered strong interest…

Concord Biotech IPO fully subscribed on day 2; retail portion booked 1.58x

Concord Biotech IPO Subscription Status: The initial public offering (IPO) of Concord Biotech Limited has been…

Concord Biotech IPO: Firm mobilises ₹465 crore from anchor investors

Concord Biotech IPO: Rare Enterprises-backed Concord Biotech said in an exchange filing that it has raised…

Concord Biotech IPO to open on August 4; Here are key things to know

Concord is one of the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants…